| |
| |
|
| Insider
Information: |
Cheung Wilson Wai-Shun |
| Relationship: |
CFO & Senior VP, Finance |
| City: |
Fremont |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,000 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,660 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,000 |
|
|
| Total
Value |
$3,660 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
AXT Inc |
AXTI |
Chief Financial Officer |
2008-11-10 |
1,000 |
2008-03-06 |
0 |
Premium* |
|
|
Sciclone Pharmaceuticals Inc |
SCLN |
CFO & Senior VP, Finance |
2017-10-13 |
0 |
2014-08-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SCLN |
Sciclone Pharmaceuticals ... |
CFO & Senior VP, Finance |
• – – |
2017-10-13 |
4 |
D |
$11.18 |
$1,611,686 |
D/D |
(144,158) |
0 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
CFO & Senior VP, Finance |
• – – |
2017-10-13 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
144,158 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
CFO & Senior VP, Finance |
• – – |
2017-10-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
52,000 |
69,158 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
CFO & Senior VP, Finance |
• – – |
2017-08-15 |
4 |
D |
$11.05 |
$162,590 |
D/D |
(14,714) |
17,158 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
CFO & Senior VP, Finance |
• – – |
2017-08-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
30,000 |
31,872 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
CFO & Senior VP, Finance |
• – – |
2017-06-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
40,500 |
42,372 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
CFO & Senior VP, Finance |
• – – |
2017-06-12 |
4 |
S |
$10.75 |
$435,375 |
D/D |
(40,500) |
1,872 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
CFO & Senior VP, Finance |
• – – |
2017-03-15 |
4 |
D |
$9.60 |
$10,829 |
D/D |
(1,128) |
1,872 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
CFO & Senior VP, Finance |
• – – |
2017-03-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,000 |
3,000 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
CFO & Senior VP, Finance |
• – – |
2016-10-26 |
4 |
OE |
$4.52 |
$739,372 |
D/D |
134,828 |
40,625 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
CFO & Senior VP, Finance |
• – – |
2016-10-26 |
4 |
AS |
$10.00 |
$1,498,920 |
D/D |
(149,892) |
0 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
CFO & Senior VP, Finance |
• – – |
2016-10-25 |
4 |
AS |
$10.00 |
$700 |
D/D |
(70) |
15,064 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
CFO & Senior VP, Finance |
• – – |
2016-10-17 |
4 |
AS |
$10.00 |
$14,750 |
D/D |
(1,475) |
15,134 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
CFO & Senior VP, Finance |
• – – |
2016-10-17 |
4 |
OE |
$5.97 |
$6,000 |
D/D |
1,005 |
16,609 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
CFO & Senior VP, Finance |
• – – |
2016-08-29 |
4 |
S |
$10.35 |
$19,370 |
D/D |
(1,872) |
15,604 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
CFO & Senior VP, Finance |
• – – |
2016-08-16 |
4 |
S |
$10.62 |
$82,837 |
D/D |
(7,802) |
17,476 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
CFO & Senior VP, Finance |
• – – |
2016-08-12 |
4 |
D |
$10.41 |
$158,461 |
D/D |
(15,222) |
25,278 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
CFO & Senior VP, Finance |
• – – |
2016-08-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
40,500 |
40,500 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
CFO & Senior VP, Finance |
• – – |
2015-11-10 |
4 |
AS |
$9.51 |
$74,207 |
D/D |
(7,803) |
0 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
CFO & Senior VP, Finance |
• – – |
2015-08-13 |
4 |
D |
$8.05 |
$37,811 |
D/D |
(4,697) |
7,803 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
CFO & Senior VP, Finance |
• – – |
2015-08-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,500 |
12,500 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
CFO & Senior VP, Finance |
• – – |
2015-03-12 |
4 |
AS |
$9.07 |
$70,773 |
D/D |
(7,803) |
0 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
CFO & Senior VP, Finance |
• – – |
2014-08-14 |
4 |
D |
$5.78 |
$27,149 |
D/D |
(4,697) |
7,803 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
CFO & Senior VP, Finance |
• – – |
2014-08-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,500 |
12,500 |
0 |
- |
|
| AXTI |
AXT Inc |
Chief Financial Officer |
• – – |
2008-11-10 |
4 |
B |
$1.26 |
$1,260 |
D/D |
1,000 |
1,000 |
2.66 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
